VANGUARD GROUP INC - NOVAVAX INC ownership

NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 378 filers reported holding NOVAVAX INC in Q1 2022. The put-call ratio across all filers is 1.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of NOVAVAX INC
ValueSharesWeighting
Q3 2023$83,632,687
+6.5%
11,551,476
+9.3%
0.00%0.0%
Q2 2023$78,554,440
+11.2%
10,572,603
+3.7%
0.00%0.0%
Q1 2023$70,644,129
-22.3%
10,193,958
+15.3%
0.00%0.0%
Q4 2022$90,923,033
-33.4%
8,844,653
+18.0%
0.00%
-50.0%
Q3 2022$136,426,000
-63.9%
7,495,924
+2.0%
0.00%
-63.6%
Q2 2022$378,058,000
-26.3%
7,350,925
+5.5%
0.01%
-8.3%
Q1 2022$513,116,000
-48.0%
6,966,943
+1.0%
0.01%
-45.5%
Q4 2021$986,754,000
-30.0%
6,897,007
+1.5%
0.02%
-37.1%
Q3 2021$1,409,086,000
-0.5%
6,796,998
+1.9%
0.04%0.0%
Q2 2021$1,416,249,000
+32.5%
6,670,660
+13.2%
0.04%
+20.7%
Q1 2021$1,068,514,000
+71.1%
5,893,304
+5.3%
0.03%
+61.1%
Q4 2020$624,317,000
+6.1%
5,598,760
+3.1%
0.02%
-5.3%
Q3 2020$588,509,000
+52.2%
5,431,560
+17.1%
0.02%
+35.7%
Q2 2020$386,547,000
+1283.1%
4,637,637
+125.4%
0.01%
+1300.0%
Q1 2020$27,947,000
+373.9%
2,057,966
+38.9%
0.00%
Q4 2019$5,897,000
-24.1%
1,481,859
-4.2%
0.00%
Q3 2019$7,765,000
-5.4%
1,546,834
+10.4%
0.00%
Q2 2019$8,208,0001,400,6660.00%
Other shareholders
NOVAVAX INC shareholders Q1 2022
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 132,500$2,414,0000.77%
HAP Trading, LLC 130,000$10,673,0000.71%
Mendel Capital Management LLC 23,835$434,0000.51%
Faithward Advisors, LLC 115,912$2,109,0000.50%
Rock Springs Capital Management LP 599,300$10,907,0000.28%
SECTOR GAMMA AS 56,735$1,033,0000.27%
Quantitative Investment Management, LLC 83,072$1,511,0000.25%
LMR Partners LLP 396,100$7,209,0000.13%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 1,333,706$24,273,0000.13%
TSP Capital Management Group, LLC 16,025$292,0000.12%
View complete list of NOVAVAX INC shareholders